Drugging the undruggable RAS: Mission possible?

AD Cox, SW Fesik, AC Kimmelman, J Luo… - Nature reviews Drug …, 2014 - nature.com
Despite more than three decades of intensive effort, no effective pharmacological inhibitors
of the RAS oncoproteins have reached the clinic, prompting the widely held perception that …

Genomic instability in cancer: teetering on the limit of tolerance

N Andor, CC Maley, HP Ji - Cancer research, 2017 - AACR
Cancer genomic instability contributes to the phenomenon of intratumoral genetic
heterogeneity, provides the genetic diversity required for natural selection, and enables the …

Variant review with the integrative genomics viewer

JT Robinson, H Thorvaldsdóttir, AM Wenger, A Zehir… - Cancer research, 2017 - AACR
Manual review of aligned reads for confirmation and interpretation of variant calls is an
important step in many variant calling pipelines for next-generation sequencing (NGS) data …

[HTML][HTML] Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression

C Yang, W Yuan, X Yang, P Li, J Wang, J Han, J Tao… - Molecular cancer, 2018 - Springer
Background Circ-ITCH is a circRNA generated from several exons of itchy E3 ubiquitin
protein ligase (ITCH) and tumor suppressor served as a sponge for certain miRNAs …

Pan-cancer analysis of the extent and consequences of intratumor heterogeneity

N Andor, TA Graham, M Jansen, LC Xia, CA Aktipis… - Nature medicine, 2016 - nature.com
Intratumor heterogeneity (ITH) drives neoplastic progression and therapeutic resistance. We
used the bioinformatics tools' expanding ploidy and allele frequency on nested …

Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets

EJ Pietzak, A Bagrodia, EK Cha, EN Drill, G Iyer… - European urology, 2017 - Elsevier
Background Molecular characterization of nonmuscle invasive bladder cancer (NMIBC) may
provide a biologic rationale for treatment response and novel therapeutic strategies …

Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

JC Taylor, HC Martin, S Lise, J Broxholme, JB Cazier… - Nature …, 2015 - nature.com
To assess factors influencing the success of whole-genome sequencing for mainstream
clinical diagnosis, we sequenced 217 individuals from 156 independent cases or families …

Non-coding RNA in bladder cancer

Y Li, G Li, X Guo, H Yao, G Wang, C Li - Cancer letters, 2020 - Elsevier
Bladder cancer is the tenth most common cancer worldwide and has been associated with
high mortality and morbidity. Although the treatment of bladder cancer is based on well …

A new tumor suppressor role for the Notch pathway in bladder cancer

T Rampias, P Vgenopoulou, M Avgeris, A Polyzos… - Nature medicine, 2014 - nature.com
The Notch signaling pathway controls cell fates through interactions between neighboring
cells by positively or negatively affecting the processes of proliferation, differentiation and …

Modelling bladder cancer in mice: opportunities and challenges

T Kobayashi, TB Owczarek, JM McKiernan… - Nature reviews …, 2015 - nature.com
The prognosis and treatment of bladder cancer have improved little in the past 20 years.
Bladder cancer remains a debilitating and often fatal disease, and is among the most costly …